Oxford BioTherapeutics
Oxford BioTherapeutics is a biotech company in Oxford, United Kingdom.
Developing First-in-Class Cancer Therapies
- Headquarters
- Oxford
- Website
- oxfordbiotherapeutics.com
Indexed holds 1 investor for this company. The full record is or through the API.
About
Oxford BioTherapeutics develops targeted oncology treatments, including antibody-drug conjugates, immuno-oncology therapies, T-cell engagers and radiopharmaceuticals. Its OGAP®-Verify proteomic platform identifies novel cancer targets to support next-generation antibody therapies. Through partnerships, the company advances first-in-class treatments intended to expand therapeutic options and improve outcomes for patients.
Summary
Investors include Silicon Valley Bank.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Company Event History
Jul 2015
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oxford-biotherapeutics"><img src="https://indexed.vc/api/badge/company/oxford-biotherapeutics" alt="Oxford BioTherapeutics on Indexed.vc" width="260" height="76" /></a>
